This will be accomplished via the unique and innovative biosampling technology set forth by Mawi DNA. BIOTESSIA’s strategy and vision are centered around ensuring health needs for every citizen through early detection of diseases.
To Read More about our joint venture please read the BusinessWire Article
|
Visit the Mawi DNA Team (Booth #1465) at ADLM 2024,…...
Every year the Association for Diagnostics & Laboratory Medicine (ADLM) (formerly AACC) gives laboratory medicine professionals the opportunity to connect with global leaders in clinical chemistry...
READ MOREVisit the Mawi DNA Team (Booth #B704) at PMWC 2024,…...
JOIN US AT PMWC | Jan. 24-26, 2024 | Silicon Valley | California READ MORE
Alternative To Blood Samples Exome Sequencing Screening...
In a study published by the NPJ Genomic Medicine, Three young children presented with a neurodevelopmental disorder were studied to identify if there were pathogenic variants found in their ATG4D bi-...
READ MORE